We're going to go on to watch regulatory together with other developments that could consequence through the proposed rescheduling and look ahead to analyzing the proper route ahead for the company and our shareholders to completely capitalize on the U.S. cannabis option.”  The Fourth Circuit Courtroom of Appeals concluded that federal law isn'